YL

Yuling Luo

Founder, Chairman & CEO, at Alamar Biosciences

Fremont, California

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $500,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $5,000,000.00

Education

Lists including Yuling

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

AB
Alamar Biosciences, Inc.

2018

  • Founder, Chairman & CEO

    2018

    Venture Partner, Illumina Ventures, 1/2020 - present Co-Founder & Chairman of BOD, Aopia Biosciences, 11/2019 - present Co-Founder & board member, Attovia Therapeutics, 2022 - present

AB
Avida Biomed

2019 - 2022

  • Co-Founder & Chairman of BOD

    2019 - 2022

    Avida Biomed was acquired by Agilent in Dec 2022

B
Bio-Techne

2016 - 2018

  • President, Advanced Cell Diagnostics

    2016 - 2018

    Retired in Feb 2018

AC
Advanced Cell Diagnostics, Inc.

2006 - 2016

  • Founder, President & CEO

    2006 - 2016

    ACD was acquired by Bio-Techne in Aug 2016

Panomics, Inc. (Genospectra)

2001 - 2009

  • Founder & VP

    2001 - 2009

    Panomics was acquired by Affymetrix in 2008 Senior Advisor 2006-2009 Founder & VP 2001-2006

E
Exelixis

1997 - 2000

  • Senior Scientist

    1997 - 2000